The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The global Pimozide market was valued at US$ 11 million in 2023 and is anticipated to reach US$ 10 million by 2030, witnessing a CAGR of -0.9% during the forecast period 2024-2030.
Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.
North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.
In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.
This report aims to provide a comprehensive presentation of the global market for Pimozide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pimozide.
Report Scope
The Pimozide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pimozide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pimozide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Segment by Type
1Mg
2Mg
4Mg
Segment by Application
Hospitals
Drugstores
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pimozide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pimozide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The global Pimozide market was valued at US$ 11 million in 2023 and is anticipated to reach US$ 10 million by 2030, witnessing a CAGR of -0.9% during the forecast period 2024-2030.
Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.
North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.
In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.
This report aims to provide a comprehensive presentation of the global market for Pimozide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pimozide.
Report Scope
The Pimozide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pimozide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pimozide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Segment by Type
1Mg
2Mg
4Mg
Segment by Application
Hospitals
Drugstores
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pimozide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pimozide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pimozide Market Overview
1.1 Product Overview and Scope of Pimozide
1.2 Pimozide Segment by Type
1.2.1 Global Pimozide Market Value Comparison by Type (2024-2030)
1.2.2 1Mg
1.2.3 2Mg
1.2.4 4Mg
1.3 Pimozide Segment by Application
1.3.1 Global Pimozide Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Global Pimozide Market Size Estimates and Forecasts
1.4.1 Global Pimozide Revenue 2019-2030
1.4.2 Global Pimozide Sales 2019-2030
1.4.3 Global Pimozide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pimozide Market Competition by Manufacturers
2.1 Global Pimozide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pimozide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pimozide Average Price by Manufacturers (2019-2024)
2.4 Global Pimozide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pimozide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pimozide, Product Type & Application
2.7 Pimozide Market Competitive Situation and Trends
2.7.1 Pimozide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pimozide Players Market Share by Revenue
2.7.3 Global Pimozide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pimozide Retrospective Market Scenario by Region
3.1 Global Pimozide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pimozide Global Pimozide Sales by Region: 2019-2030
3.2.1 Global Pimozide Sales by Region: 2019-2024
3.2.2 Global Pimozide Sales by Region: 2025-2030
3.3 Global Pimozide Global Pimozide Revenue by Region: 2019-2030
3.3.1 Global Pimozide Revenue by Region: 2019-2024
3.3.2 Global Pimozide Revenue by Region: 2025-2030
3.4 North America Pimozide Market Facts & Figures by Country
3.4.1 North America Pimozide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pimozide Sales by Country (2019-2030)
3.4.3 North America Pimozide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pimozide Market Facts & Figures by Country
3.5.1 Europe Pimozide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pimozide Sales by Country (2019-2030)
3.5.3 Europe Pimozide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pimozide Market Facts & Figures by Country
3.6.1 Asia Pacific Pimozide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pimozide Sales by Country (2019-2030)
3.6.3 Asia Pacific Pimozide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pimozide Market Facts & Figures by Country
3.7.1 Latin America Pimozide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pimozide Sales by Country (2019-2030)
3.7.3 Latin America Pimozide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pimozide Market Facts & Figures by Country
3.8.1 Middle East and Africa Pimozide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pimozide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pimozide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pimozide Sales by Type (2019-2030)
4.1.1 Global Pimozide Sales by Type (2019-2024)
4.1.2 Global Pimozide Sales by Type (2025-2030)
4.1.3 Global Pimozide Sales Market Share by Type (2019-2030)
4.2 Global Pimozide Revenue by Type (2019-2030)
4.2.1 Global Pimozide Revenue by Type (2019-2024)
4.2.2 Global Pimozide Revenue by Type (2025-2030)
4.2.3 Global Pimozide Revenue Market Share by Type (2019-2030)
4.3 Global Pimozide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pimozide Sales by Application (2019-2030)
5.1.1 Global Pimozide Sales by Application (2019-2024)
5.1.2 Global Pimozide Sales by Application (2025-2030)
5.1.3 Global Pimozide Sales Market Share by Application (2019-2030)
5.2 Global Pimozide Revenue by Application (2019-2030)
5.2.1 Global Pimozide Revenue by Application (2019-2024)
5.2.2 Global Pimozide Revenue by Application (2025-2030)
5.2.3 Global Pimozide Revenue Market Share by Application (2019-2030)
5.3 Global Pimozide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Pimozide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Pimozide Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Par Pharmaceutical
6.2.1 Par Pharmaceutical Corporation Information
6.2.2 Par Pharmaceutical Description and Business Overview
6.2.3 Par Pharmaceutical Pimozide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Par Pharmaceutical Pimozide Product Portfolio
6.2.5 Par Pharmaceutical Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Pimozide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Pimozide Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Eumedica
6.4.1 Eumedica Corporation Information
6.4.2 Eumedica Description and Business Overview
6.4.3 Eumedica Pimozide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eumedica Pimozide Product Portfolio
6.4.5 Eumedica Recent Developments/Updates
6.5 Pharmascience
6.5.1 Pharmascience Corporation Information
6.5.2 Pharmascience Description and Business Overview
6.5.3 Pharmascience Pimozide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pharmascience Pimozide Product Portfolio
6.5.5 Pharmascience Recent Developments/Updates
6.6 Domina Pharmaceuticals
6.6.1 Domina Pharmaceuticals Corporation Information
6.6.2 Domina Pharmaceuticals Description and Business Overview
6.6.3 Domina Pharmaceuticals Pimozide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Domina Pharmaceuticals Pimozide Product Portfolio
6.6.5 Domina Pharmaceuticals Recent Developments/Updates
6.7 Aa Pharma
6.6.1 Aa Pharma Corporation Information
6.6.2 Aa Pharma Description and Business Overview
6.6.3 Aa Pharma Pimozide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aa Pharma Pimozide Product Portfolio
6.7.5 Aa Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pimozide Industry Chain Analysis
7.2 Pimozide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pimozide Production Mode & Process
7.4 Pimozide Sales and Marketing
7.4.1 Pimozide Sales Channels
7.4.2 Pimozide Distributors
7.5 Pimozide Customers
8 Pimozide Market Dynamics
8.1 Pimozide Industry Trends
8.2 Pimozide Market Drivers
8.3 Pimozide Market Challenges
8.4 Pimozide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
